Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

[Article in Russian]

Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB.

Abstract

Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients). Patient's state was assessed with psychometric scales (Hamilton, Zung, CGI). Enkephalin activity in the blood serum was measured as well. The anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects. The clinical-biological study revealed that patients with GAD and neurasthenia had the decreased level of tau(1/2) leu-enkephalin which was correlated with disease duration, severity of symptoms related to anxiety and asthenia and autonomic disorders. The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.

PMID:: 18454096; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Anxiety - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. [J Clin Psychopharmacol. 2009]
A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. J Clin Psychopharmacol. 2009 Aug; 29(4):378-82.
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. [J Affect Disord. 2009]
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T. J Affect Disord. 2009 Jun; 115(3):376-85. Epub 2008 Nov 29.
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. [Bull Exp Biol Med. 2001]
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.
Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, Grivennikov IA, Andreeva LN, Zolotarev YA, Ivanov SV, Andryushchenko AV, Myasoedov NF, et al. Bull Exp Biol Med. 2001 Apr; 131(4):315-7.
Review Duloxetine: a review of its use in the treatment of generalized anxiety disorder. [CNS Drugs. 2009]
Review Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ, McCormack PL. CNS Drugs. 2009; 23(6):523-41.
Review [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. [Encephale. 2008]
Review [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A. Encephale. 2008 Sep; 34(4):400-8. Epub 2008 Aug 15.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank i...
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].
Zh Nevrol Psikhiatr Im S S Korsakova. 2008 ;108(4):38-48.

PubMed
Traumatic brain injuries in early childhood: initial impact on the family.
Traumatic brain injuries in early childhood: initial impact on the family.
J Dev Behav Pediatr. 2008 Aug ;29(4):253-61.

PubMed
Complications after polymethylmethacrylate injections: report of 32 cases.
Complications after polymethylmethacrylate injections: report of 32 cases.
Plast Reconstr Surg. 2008 May ;121(5):1811-20.

PubMed
What is spiritual care in nursing? Findings from an exercise in content validity...
What is spiritual care in nursing? Findings from an exercise in content validity.
Holist Nurs Pract. 2008 May-Jun ;22(3):154-9.

PubMed
Transplantation of the major salivary glands.
Transplantation of the major salivary glands.
Dev Ophthalmol. 2008 ;41:255-68.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information